Story
Cardinal Health Stock Rises on Long-Term CVS Contract Extension, Reaffirmed Guidance
Cardinal Health (NYSE:CAH) shares climbed 3.8% in afternoon trading after the company announced a long-term extension of its pharmaceutical distribution agreement with key customer CVS Health. The company also reaffirmed its fiscal 2027 earnings forecast, removing a significant source of investor uncertainty and boosting confidence in its long-term stability.
Key Agreement Secured
Cardinal Health announced it has entered into a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032. The deal maintains the current scope of distribution services, solidifying a critical, long-term revenue stream for the company.
CVS Health represents one of Cardinal Health’s most significant client relationships. Securing the contract for the remainder of the decade provides enhanced revenue visibility and stability for the company's core pharmaceutical segment.
Guidance and Investor Confidence
In conjunction with the contract news, Cardinal Health reaffirmed its fiscal year 2027 guidance for non-GAAP earnings per share of $12.40 to $12.60. This target represents a projected growth rate of 13% to 15%, signaling to investors that management's long-term business outlook remains intact.
AdAdding to the day's catalysts, the company noted that the stock's ex-dividend date for its quarterly cash dividend of approximately $0.516 per share was also today. Cardinal Health confirmed it will release its first-quarter fiscal 2027 financial results on November 5.
Market Reaction
The stock's strong performance significantly outpaced the broader market, which saw only modest gains. The S&P 500 was up approximately 0.4%, indicating that Cardinal Health's rally was driven by company-specific news rather than a wider market trend.
Investors reacted positively to the combination of the secured contract and the confirmed financial targets, which together address key questions about the company's future revenue and profitability.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.